Fig. 3From: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trialPrognostic impact of HM metascore and rISS. Shown are progression-free (PFS) and overall survival (OS) for a our HM metacore as well as b the revised International Staging System (rISS)Back to article page